Bill Tansey

  • Vanderbilt University

    Vanderbilt-Ingram Cancer Center names Tansey, Kojetin to leadership team

    Vanderbilt-Ingram names William Tansey associate director for Shared Resources and Douglas Kojetin as co-leader of the Genome Maintenance Research Program. The Genome Maintenance Research Program is focused on understanding how DNA is damaged, repaired, packaged, expressed and replicated. Read More

    Sep. 20, 2025

  • Vanderbilt University

    NCI grant funds $12 million for colorectal cancer research

    A colorectal cancer research team led by Robert Coffey has received a Specialized Programs of Research Excellence grant renewal totaling $12.6 million from the National Cancer Institute.The team has made numerous discoveries over the past 23 years, and it plans to build upon those achievements with the goal of “drugging the undruggable.” Vanderbilt-Ingram is one of only four cancer centers in the U.S. with GI Cancer SPORE funding. Read More

    Sep. 15, 2025

  • Vanderbilt University

    New cancer target could push new drugs into the clinic

    New work by Professor of Cell and Developmental Biology Bill Tansey and colleagues has determined that a new type of inhibitor—a WINi—targets cancer cells in a novel way and suggests exploiting this pathway in future anticancer drug development efforts. Read More

    May. 14, 2024